Agios Pharmaceuticals, Inc. (AGIO) ownership: Entities affiliated with Farallon Capital Partners, L.P. 14% · institutions 110% (13F 2026-03-31). Insider activity, 90 days: Routine (2 sales, 0 open-market buys). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 5754957.00 | $194.69M | 9.7% | 2026-03-31 |
| Vanguard | 5720909.00 | $193.54M | 9.6% | 2026-03-31 |
| Farallon Capital Management LLC | 5684000.00 | $192.29M | 9.6% | 2026-03-31 |
| State Street | 3364879.00 | $113.72M | 5.7% | 2026-03-31 |
| Armistice Capital, LLC | 2716000.00 | $91.88M | 4.6% | 2026-03-31 |
| D. E. Shaw | 2681169.00 | $90.70M | 4.5% | 2026-03-31 |
| Lynx1 Capital Management LP | 2611568.00 | $88.35M | 4.4% | 2026-03-31 |
| Erste Asset Management GmbH | 2704900.00 | $80.09M | 4.5% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-07-08 | |
| Sell | null | 2026-07-08 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 |
Back to AGIO overview · AGIO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.